Immune Checkpoint Inhibitors in Cancer TreatmentEvery major pharmaceutical and biotechnology company hopes to create the next blockbuster drug that will benefit all patients. An example…Sep 25, 20232Sep 25, 20232
Explosion of Antibody Drug Conjugates in CancerSince the approval of Mylotarg in 2000, there have been only 13 antibody-drug conjugates (ADCs) approved worldwide on the market, with over…Sep 18, 20234Sep 18, 20234
Emerging Approach to Cancer Therapy — Targeted Protein DegradersChemotherapy, radiation, and surgery have been the mainstays of cancer treatment. Patients have endured long-term toxicities as a result of…Sep 11, 20232Sep 11, 20232
Introduction: Alexander AnHello! My name is Alex An and I am a 3rd-year pharmacy student at UNC Eshelman School of Pharmacy. I want to start a blog series about…Sep 8, 20232Sep 8, 20232
